LGND CIK: 886163

Ligand Pharmaceuticals Incorporated

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY22
millions USD
FY21:
179
FY22:
143
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
138
FY22:
3.04
FY23:
11.9
FY24:
−22.6
FY25:
41.0
(positive)
Change from FY21 to FY22
millions USD
FY21:
148
FY22:
60.6
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
72.2
FY22:
36.0
FY23:
63.7
FY24:
2.52
FY25:
159
(positive)
Change from FY21 to FY25
millions USD
FY21:
57.1
FY22:
−33.4
FY23:
52.2
FY24:
−4.03
FY25:
124

All amounts in millions USD Data sources:SEC EDGARTwelve Data